Related Experiment Video
Updated: May 30, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer
Nigus D Ambaye1, Stephanie C Pero, Menachem J Gunzburg
1Department of Biochemistry and Molecular Biology, Monash University, Wellington Road, VIC 3800, Australia.
Abstract:
Growth-receptor-bound protein (Grb)7 is an adapter protein aberrantly overexpressed, along with the erbB-2 receptor in breast cancer and in other cancers. Normally recruited to focal adhesions with a role in cell migration, it is associated with erbB-2 in cancer cells and is found to exacerbate cancer progression via stimulation of cell migration and proliferation. The G7-18NATE peptide (sequence: WFEGYDNTFPC cyclized via a thioether bond) is a nonphosphorylated peptide that was developed for the specific inhibition of Grb7 by blocking its SH2 domain. Cell-permeable versions of G7-18NATE are effective in the reduction of migration and proliferation in Grb7-overexpressing cells. It thus represents a promising starting point for the development of a therapeutic against Grb7. Here, we report the crystal structure of the G7-18NATE peptide in complex with the Grb7-SH2 domain, revealing the structural basis for its interaction. We also report further rounds of phage display that have identified G7-18NATE analogues with micromolar affinity for Grb7-SH2. These peptides retained amino acids F2, G4, and F9, as well as the YDN motif that the structural biology study showed to be the main residues in contact with the Grb7-SH2 domain. Isothermal titration calorimetry measurements reveal similar and better binding affinity of these peptides compared with G7-18NATE. Together, this study facilitates the optimization of second-generation inhibitors of Grb7.
Insights
A novel peptide inhibitor, G7-18NATE, effectively blocks Growth-receptor-bound protein 7 (Grb7) in cancer cells. This study reveals its structural interaction and identifies improved analogues for potential Grb7-targeted cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Growth-receptor-bound protein 7 (Grb7) is overexpressed in various cancers, correlating with erbB-2 receptor presence.
- Grb7 promotes cancer progression by enhancing cell migration and proliferation.
- Inhibiting Grb7 activity presents a therapeutic strategy for cancer treatment.
Purpose of the Study:
- To elucidate the structural basis of G7-18NATE peptide inhibition of the Grb7 SH2 domain.
- To identify and characterize novel Grb7 inhibitors with improved binding affinity.
- To facilitate the development of second-generation Grb7-targeted therapeutics.
Main Methods:
- X-ray crystallography to determine the Grb7-SH2 domain-G7-18NATE complex structure.
- Phage display for identifying Grb7-SH2 binding peptide analogues.
- Isothermal titration calorimetry to assess binding affinities of identified peptides.
Main Results:
- The crystal structure reveals the specific interaction between G7-18NATE and the Grb7-SH2 domain.
- Phage display identified G7-18NATE analogues with retained key amino acids (F2, G4, F9, YDN motif) and micromolar affinity.
- Isothermal titration calorimetry confirmed similar or improved binding affinities for the novel analogues compared to G7-18NATE.
Conclusions:
- The G7-18NATE peptide provides a structural foundation for Grb7 inhibition.
- Optimized peptide analogues demonstrate enhanced binding to Grb7-SH2.
- This research paves the way for developing effective Grb7-based cancer therapies.
More Related Videos
10:52A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning
Published on: October 30, 2012
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
Related Concept Videos
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
GPCRs Regulate Adenylyl Cylase Activity
Two...
Intracellular Signaling Affects Focal Adhesions
Some...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade